College of Nursing, Medical University of South Carolina, Charleston, South Carolina.
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.
J Pain. 2023 Jul;24(7):1240-1250. doi: 10.1016/j.jpain.2023.02.022. Epub 2023 Feb 28.
Pain is a significant symptom experienced frequently by individuals with sickle cell disease (SCD). Pain management includes strategies such as oral rehydration, non-pharmacological therapies (eg, massage, relaxation), and oral analgesics and opioids. Shared decision-making around pain management is emphasized repeatedly in recent guidelines; however, research is sparse regarding factors to be considered in shared decision-making approaches including the perceived risks and benefits of opioids. This qualitative descriptive study was conducted to explore perspectives of decision-making for opioid medications in SCD. We conducted 20 in-depth interviews with caregivers of children with SCD and individuals with SCD to elucidate the decision-making processes around home use of opioid therapy for pain management at a single center. Themes were identified in the domains of the Decision Problem (Alternatives and Choices; Outcomes and Consequences; Complexity), the Context (Multilevel Stressors and Supports; Information; Patient-Provider Interactions), and the Patient (Decision-Making Approaches; Developmental Status; Personal and Life Values; Psychological State). Key findings indicated opioid management for pain in SCD is important yet complex and requires collaboration among patients, families, and providers. Elements of patient and caregiver decision-making identified in this study may be applied to shared decision-making strategies in the clinical setting and future study. PERSPECTIVE: This study illustrates the factors involved in decision-making around home opioid use for pain management in children and young adults with SCD. These findings can be applied to determining shared decision-making approaches around pain management between providers and patients, in accordance with recent SCD pain management guidelines.
疼痛是镰状细胞病(SCD)患者经常经历的一种严重症状。疼痛管理包括口服补液、非药物治疗(如按摩、放松)和口服镇痛药和阿片类药物等策略。最近的指南反复强调了疼痛管理中的共同决策,但关于共同决策方法中要考虑的因素(包括阿片类药物的感知风险和益处)的研究很少。这项定性描述性研究旨在探讨 SCD 中阿片类药物决策的观点。我们在一家中心对儿童 SCD 照顾者和 SCD 患者进行了 20 次深入访谈,以阐明家庭使用阿片类药物治疗疼痛管理的决策过程。在决策问题(替代方案和选择;结果和后果;复杂性)、背景(多层次压力源和支持;信息;医患互动)和患者(决策方法;发展状况;个人和生活价值观;心理状态)领域确定了主题。主要发现表明,SCD 中的疼痛管理虽然重要但很复杂,需要患者、家庭和提供者之间的合作。本研究中确定的患者和照顾者决策因素可应用于临床实践中的共同决策策略和未来的研究。观点:本研究说明了在 SCD 儿童和年轻人中,家庭使用阿片类药物治疗疼痛管理的决策中涉及的因素。这些发现可用于根据最近的 SCD 疼痛管理指南确定提供者和患者之间的疼痛管理共同决策方法。